Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count

HIV-infected patients are 30- to 100-fold more susceptible to invasive pneumococcal diseases than are healthy adults. Pneumococcal vaccination may be the best way to decrease the large pneumococcal disease burden, but the optimal timing of vaccination is still unclear. In this study, HIV-infected su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Song, Joon Young, Cheong, Hee Jin, Noh, Ji Yun, Choi, Min Joo, Yoon, Jin Gu, Kim, Woo Joo
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012181/
https://ncbi.nlm.nih.gov/pubmed/31441710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1643677
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares